Results 131 to 140 of about 19,620 (245)
Chuyen Thi Hong Nguyen, Nguyet Huu Minh Nguyen, Trung The Van Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, 700000, VietnamCorrespondence: Chuyen Thi Hong Nguyen, Department of Dermatology, University of Medicine and
Nguyen NHM, Nguyen CTH, Van TT
core
Medical devices for restless legs syndrome – clinical utility of the Relaxis pad
, 2015 Ulrike H Mitchell Department of Exercise Sciences, Brigham Young University, Provo, UT, USA Abstract: Restless Legs Syndrome or Willis–Ekbom Disease, a neurosensory disorder, can be treated with pharmaceuticals or conservatively.
Mitchell UH
core
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 1, July 2026.ABSTRACT Dopaminergic medication used in disorders like Parkinson's disease (PD) and restless legs syndrome can cause impulsive‐compulsive behaviour (ICB), often with strong negative effects on patients' quality of life. This narrative review presents translational evidence on iatrogenic ICB, taking findings from epidemiological, clinical, neuroimaging
Mirjam Wolfschlag +7 more
wiley +1 more source
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.Abstract INTRODUCTION This secondary analysis examined whether mild cognitive impairment (MCI) moderates the effectiveness of non‐pharmacological insomnia therapy and whether insomnia therapy is associated with clinically meaningful symptom reduction. METHODS Cognitively intact (CI; n = 87) and MCI (n = 38) older adults with insomnia completed insomnia
Kathleen P. O'Hora +12 more
wiley +1 more source
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.Abstract INTRODUCTION Insomnia is associated with increased risk for Alzheimer's disease (AD). It is unknown how cognitive behavioral therapy for insomnia (CBT‐I) impacts two hallmarks of AD progression, cognitive performance and beta‐amyloid (Aβ) burden.
Catherine F. Siengsukon +12 more
wiley +1 more source
Rethinking clinical trials in restless legs syndrome: A roadmap.
The number of large clinical trials of restless legs syndrome (RLS) have decreased in recent years, this coincides with reduced interest in developing and testing novel pharmaceuticals.
Högl, Birgit +11 more
core +1 more source
Restless Legs Syndrome: The under-recognised condition
, 2006 Up to 15% of the adult population experiences restless legs or Ekbom syndrome during their life [1]. The patients may present to a wide range of medical specialities such as general practitioners, general physicians, nephrologists, haematologists ...
Benamer, H, Hani Benamer
core +1 more source
Epileptic Disorders, Volume 28, Issue 3, Page 775-785, June 2026.Abstract Objective Patients with drug‐resistant epilepsy (DRE) typically take multiple anti‐seizure medications (ASMs) and are at risk of treatment‐related adverse events (AEs). This study assessed the impact of cenobamate monotherapy or dual therapy in patients with drug‐resistant epilepsy.
Álvaro Sánchez‐Guijo Benavente +13 more
wiley +1 more source
Secondary restless legs syndrome
Chinese Journal of Contemporary Neurology and Neurosurgery, 2013 This paper reviewed the latest findings related to secondary restless legs syndrome (RLS) systematically. There were a variety of causes. Renal failure, injury of spinal cord and peripheral nerve were related risk factors. During pregnancy, the levels of
Yun SHEN, Cheng-jie MAO, Chun-feng LIU
doaj
Restless Legs Syndrome in Hemodialysis Patients: Clinical and Electrophysiological Study
Ying Lv,1,* Kun Zou,2,* Shanshan Zhuang,3 Yang Zhou,1 Yaping Weng,3 Enna Mi,1 Minzhu Xie,1 Long Wang1 1Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang,People’s Republic of China; 2Department of ...
Zou K +7 more
core